5α -Reductase
3-Oxo-5 | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
EC no. | 1.3.1.22 | ||||||||
CAS no. | 9036-43-5 | ||||||||
Databases | |||||||||
IntEnz | IntEnz view | ||||||||
BRENDA | BRENDA entry | ||||||||
ExPASy | NiceZyme view | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
Steroid-5 | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | SRD5A1 | ||||||
NCBI gene | 6715 | ||||||
HGNC | 11284 | ||||||
OMIM | 184753 | ||||||
RefSeq | NM_001047 | ||||||
UniProt | P18405 | ||||||
Other data | |||||||
EC number | 1.3.1.22 | ||||||
Locus | Chr. 5 p15 | ||||||
|
Steroid-5 | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | SRD5A2 | ||||||
NCBI gene | 6716 | ||||||
HGNC | 11285 | ||||||
OMIM | 607306 | ||||||
RefSeq | NM_000348 | ||||||
UniProt | P31213 | ||||||
Other data | |||||||
EC number | 1.3.1.22 | ||||||
Locus | Chr. 2 p23 | ||||||
|
5
5
- a 3-oxo-5
α -steroid + acceptor ⇌ a 3-oxo-Δ 4-steroid + reduced acceptor
Where a 3-oxo-5
- dihydrotestosterone + NADP+ testosterone + NADPH + H+
where dihydrotestosterone is the 3-oxo-5
Production and activity[edit]
The enzyme is produced in many tissues in both males and females, in the reproductive tract, testes and ovaries,[1] skin, seminal vesicles, prostate, epididymis and many organs,[2] including the nervous system.[3][4] There are three isoenzymes of 5
5
Distribution with age[edit]
5
After birth, the 5
5
In adulthood, 5
Substrates[edit]
Specific substrates include testosterone, progesterone, androstenedione,[9] epitestosterone, cortisol, aldosterone, and deoxycorticosterone. Outside of dihydrotestosterone, much of the physiological role of 5
5
Testosterone[edit]
5
The major difference is the
List of conversions[edit]
The following reactions are known to be catalyzed by 5
- Cholestenone → 5
α -Cholestanone - Progesterone → 5
α -Dihydroprogesterone - 3
α -Dihydroprogesterone → Allopregnanolone - 3
β -Dihydroprogesterone → Isopregnanolone - Deoxycorticosterone → 5
α -Dihydrodeoxycorticosterone - Corticosterone → 5
α -Dihydrocorticosterone - Aldosterone → 5
α -Dihydroaldosterone - Androstenedione → 5
α -Androstanedione - Testosterone → 5
α -Dihydrotestosterone - Nandrolone → 5
α -Dihydronandrolone
Structure[edit]
5
Inhibition[edit]
The mechanism of 5
Inhibition of the enzyme can be classified into two categories: steroidal, which are irreversible, and nonsteroidal. There are more steroidal inhibitors, with examples including finasteride (MK-906), dutasteride (GG745), 4-MA, turosteride, MK-386, MK-434, and MK-963. Researchers have pursued synthesis of nonsteroidals to inhibit 5
Additionally, it has been claimed that alfatradiol works through this mechanism of activity (5
Inhibition of 5
Gynecomastia, erectile dysfunction, impaired cognitive function, fatigue, hypoglycemia, impaired liver function, constipation, and depression, are only a few of the possible side-effects of 5
Finasteride[edit]
Finasteride inhibits two 5
Dutasteride[edit]
Dutasteride inhibits 5
Congenital deficiencies[edit]
5α -Reductase 1[edit]
5
5α -Reductase 2[edit]
Impaired 5
5α -Reductase 3[edit]
When small interfering RNA is used to knock down the expression of 5
Congenital deficiency of 5
Nervous system[edit]
Affective disorders[edit]
Isolation rearing has been shown to lower protein expression of 5
Hypothalamic–pituitary–adrenal axis dysfunction[edit]
An alternative mechanism of cortisol regulation is regulated via 5
Nomenclature[edit]
This enzyme belongs to the family of oxidoreductases, to be specific, those acting on the CH-CH group of donor with other acceptors. The systematic name of this enzyme class is 3-oxo-5
- 5
α -Reductase - 3-Oxosteroid
Δ 4-dehydrogenase - 3-Oxo-5
α -steroidΔ 4-dehydrogenase - Steroid
Δ 4-5α -reductase Δ 4-3-Keto steroid 5α -reductaseΔ 4-3-Oxo steroid reductaseΔ 4-3-Ketosteroid-5α -oxidoreductaseΔ 4-3-Oxosteroid-5α -reductase- 3-Keto-
Δ 4-steroid-5α -reductase - Testosterone 5
α -reductase - 4-Ene-3-ketosteroid-5
α -oxidoreductase Δ 4-5α -Dehydrogenase- 3-Oxo-5
α -steroid:(acceptor)Δ 4-oxidoreductase
See also[edit]
- Steroidogenic enzyme
- Acne vulgaris
- Cholestenone 5
α -reductase - Hirsutism
- Lower urinary tract symptoms
- Polycystic ovarian syndrome
- List of steroid metabolism modulators
References[edit]
- ^ Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E (October 2008). "Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice". Neurochemical Research. 33 (10): 1990–2007. doi:10.1007/s11064-008-9718-5. PMID 18473173. S2CID 19338424.
- ^ a b c d Yamana K, Labrie F, Luu-The V (August 2010). "Human type 3 5
α -reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride". Hormone Molecular Biology and Clinical Investigation. 2 (3): 293–9. doi:10.1515/hmbci.2010.035. PMID 25961201. S2CID 28841145. - ^ a b c Agís-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, Costa E, et al. (September 2006). "Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis". Proceedings of the National Academy of Sciences of the United States of America. 103 (39): 14602–7. Bibcode:2006PNAS..10314602A. doi:10.1073/pnas.0606544103. PMC 1600006. PMID 16984997.
- ^ a b Agís-Balboa RC, Pinna G, Pibiri F, Kadriu B, Costa E, Guidotti A (November 2007). "Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice". Proceedings of the National Academy of Sciences of the United States of America. 104 (47): 18736–41. Bibcode:2007PNAS..10418736A. doi:10.1073/pnas.0709419104. PMC 2141846. PMID 18003893.
- ^ Killian J, Pratis K, Clifton RJ, Stanton PG, Robertson DM, O'Donnell L (May 2003). "5alpha-reductase isoenzymes 1 and 2 in the rat testis during postnatal development". Biology of Reproduction. 68 (5): 1711–8. doi:10.1095/biolreprod.102.009142. PMID 12606426.
- ^ a b Thiele S, Hoppe U, Holterhus PM, Hiort O (June 2005). "Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males". European Journal of Endocrinology. 152 (6): 875–80. doi:10.1530/eje.1.01927. PMID 15941927.
- ^ Godoy A, Kawinski E, Li Y, Oka D, Alexiev B, Azzouni F, et al. (July 2011). "5
α -reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression". The Prostate. 71 (10): 1033–46. doi:10.1002/pros.21318. PMC 4295561. PMID 21557268. - ^ a b c d e f g Azzouni F, Godoy A, Li Y, Mohler J (2012). "The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases". Advances in Urology. 2012: 530121. doi:10.1155/2012/530121. PMC 3253436. PMID 22235201.
- ^ a b Paba S, Frau R, Godar SC, Devoto P, Marrosu F, Bortolato M (2011). "Steroid 5
α -reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders". Current Pharmaceutical Design. 17 (2): 151–67. doi:10.2174/138161211795049589 (inactive 2024-04-11). PMID 21361868.{{cite journal}}
: CS1 maint: DOI inactive as of April 2024 (link) - ^ Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, et al. (2006). "A new look at the 5alpha-reductase inhibitor finasteride". CNS Drug Reviews. 12 (1): 53–76. doi:10.1111/j.1527-3458.2006.00053.x. PMC 6741762. PMID 16834758.
- ^ Weinstein BI, Kandalaft N, Ritch R, Camras CB, Morris DJ, Latif SA, et al. (June 1991). "5 alpha-dihydrocortisol in human aqueous humor and metabolism of cortisol by human lenses in vitro". Investigative Ophthalmology & Visual Science. 32 (7): 2130–5. PMID 2055703.
- ^ Kenyon CJ, Brem AS, McDermott MJ, Deconti GA, Latif SA, Morris DJ (May 1983). "Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone". Endocrinology. 112 (5): 1852–6. doi:10.1210/endo-112-5-1852. PMID 6403339.
- ^ Ahmed S, Denison S (September 1998). "Mechanism based representation of the active site of 5 alpha-reductase (5AR)". Bioorganic & Medicinal Chemistry Letters. 8 (18): 2615–70. doi:10.1016/S0960-894X(98)00463-6. PMID 9873591.
- ^ Milewich L, Gomez-Sanchez C, Crowley G, Porter JC, Madden JD, MacDonald PC (October 1977). "Progesterone and 5alpha-pregnane-3,20-dione in peripheral blood of normal young women: Daily measurements throughout the menstrual cycle". The Journal of Clinical Endocrinology and Metabolism. 45 (4): 617–22. doi:10.1210/jcem-45-4-617. PMID 914969.
- ^ Wilson JD (8 February 2002). "The role of 5alpha-reduction in steroid hormone physiology". Reproduction, Fertility, and Development. 13 (7–8): 673–8. doi:10.1071/rd01074. PMID 11999320. Archived from the original on 26 May 2021. Retrieved 6 March 2021.
- ^ a b Han Y, Zhuang Q, Sun B, Lv W, Wang S, Xiao Q, et al. (January 2021). "Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism". Nature Communications. 12 (1): 449. Bibcode:2021NatCo..12..449H. doi:10.1038/s41467-020-20675-2. PMC 7815742. PMID 33469028.
- ^ a b Xiao Q, Wang L, Supekar S, Shen T, Liu H, Ye F, et al. (October 2020). "Structure of human steroid 5
α -reductase 2 with the anti-androgen drug finasteride". Nature Communications. 11 (1): 5430. Bibcode:2020NatCo..11.5430X. doi:10.1038/s41467-020-19249-z. PMC 7591894. PMID 33110062. - ^ Nakayama O, Yagi M, Kiyoto S, Okuhara M, Kohsaka M (December 1990). "Riboflavin, a testosterone 5 alpha-reductase inhibitor". The Journal of Antibiotics. 43 (12): 1615–6. doi:10.7164/antibiotics.43.1615. PMID 2276981.
- ^ Andersson S (2001). "Steroidogenic enzymes in skin". European Journal of Dermatology. 11 (4): 293–5. PMID 11399532.
- ^ Irwig MS, Kolukula S (June 2011). "Persistent sexual side effects of finasteride for male pattern hair loss". The Journal of Sexual Medicine. 8 (6): 1747–53. doi:10.1111/j.1743-6109.2011.02255.x. PMID 21418145.
- ^ Tian G, Stuart JD, Moss ML, Domanico PL, Bramson HN, Patel IR, et al. (March 1994). "17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1". Biochemistry. 33 (8): 2291–6. doi:10.1021/bi00174a041. PMID 8117686.
- ^ McConnell JD, Wilson JD, George FW, Geller J, Pappas F, Stoner E (March 1992). "Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia". The Journal of Clinical Endocrinology and Metabolism. 74 (3): 505–8. doi:10.1210/jcem.74.3.1371291. PMID 1371291.
- ^ Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S (May 2004). "Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor". The Journal of Clinical Endocrinology and Metabolism. 89 (5): 2179–84. doi:10.1210/jc.2003-030330. PMID 15126539.
- ^ Andriole GL, Humphrey P, Ray P, Gleave ME, Trachtenberg J, Thomas LN, et al. (September 2004). "Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer". The Journal of Urology. 172 (3): 915–9. doi:10.1097/01.ju.0000136430.37245.b9. PMID 15310997.
- ^ Gleave M, Qian J, Andreou C, Pommerville P, Chin J, Casey R, et al. (November 2006). "The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study". The Prostate. 66 (15): 1674–85. doi:10.1002/pros.20499. PMID 16927304. S2CID 40446842.
- ^ Moss GP (December 1989). "IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). The nomenclature of steroids. Recommendations 1989". European Journal of Biochemistry. 186 (3): 429–58. doi:10.1111/j.1432-1033.1989.tb15228.x. PMID 2606099.
- ^ Drury JE, Di Costanzo L, Penning TM, Christianson DW (July 2009). "Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex". The Journal of Biological Chemistry. 284 (30): 19786–90. doi:10.1074/jbc.c109.016931. PMC 2740403. PMID 19515843.
- ^ Hulin-Curtis SL, Petit D, Figg WD, Hsing AW, Reichardt JK (December 2010). "Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer". Future Oncology. 6 (12): 1897–913. doi:10.2217/fon.10.149. PMC 6300128. PMID 21142863.
- ^ Windahl SH, Andersson N, Börjesson AE, Swanson C, Svensson J, Movérare-Skrtic S, et al. (2011). Vanacker JM (ed.). "Reduced bone mass and muscle strength in male 5
α -reductase type 1 inactivated mice". PLOS ONE. 6 (6): e21402. Bibcode:2011PLoSO...621402W. doi:10.1371/journal.pone.0021402. PMC 3120862. PMID 21731732. - ^ Sinnecker GH, Hiort O, Dibbelt L, Albers N, Dörr HG, Hauß H, et al. (3 May 1996). "Phenotypic classification of male pseudohermaphroditism due to steroid 5
α -reductase 2 deficiency". American Journal of Medical Genetics. 63 (1): 223–230. doi:10.1002/(SICI)1096-8628(19960503)63:1<223::AID-AJMG39>3.0.CO;2-O. PMID 8723114. - ^ Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, et al. (January 2008). "Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer". Cancer Science. 99 (1): 81–6. doi:10.1111/j.1349-7006.2007.00656.x. PMID 17986282. S2CID 51733620.
- ^ Cantagrel V, Lefeber DJ, Ng BG, Guan Z, Silhavy JL, Bielas SL, et al. (July 2010). "SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder". Cell. 142 (2): 203–17. doi:10.1016/j.cell.2010.06.001. PMC 2940322. PMID 20637498.
- ^ Bortolato M, Devoto P, Roncada P, Frau R, Flore G, Saba P, et al. (June 2011). "Isolation rearing-induced reduction of brain 5
α -reductase expression: relevance to dopaminergic impairments". Neuropharmacology. 60 (7–8): 1301–8. doi:10.1016/j.neuropharm.2011.01.013. PMID 21256141. S2CID 20164197. - ^ Giatti S, Diviccaro S, Panzica G, Melcangi RC (August 2018). "Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?". Endocrine. 61 (2): 180–193. doi:10.1007/s12020-018-1593-5. PMID 29675596. S2CID 4974636.
- ^ a b Frau R, Bini V, Soggiu A, Scheggi S, Pardu A, Fanni S, et al. (October 2017). "The Neurosteroidogenic Enzyme 5
α -Reductase Mediates Psychotic-Like Complications of Sleep Deprivation". Neuropsychopharmacology. 42 (11): 2196–2205. doi:10.1038/npp.2017.13. PMC 5603808. PMID 28102229. - ^ a b Welk B, McArthur E, Ordon M, Anderson KK, Hayward J, Dixon S (May 2017). "Association of Suicidality and Depression With 5
α -Reductase Inhibitors". JAMA Internal Medicine. 177 (5): 683–691. doi:10.1001/jamainternmed.2017.0089. PMC 5818776. PMID 28319231. - ^ a b Dyson TE, Cantrell MA, Lund BC (October 2020). "Lack of Association between 5
α -Reductase Inhibitors and Depression". The Journal of Urology. 204 (4): 793–798. doi:10.1097/JU.0000000000001079. PMID 32294395. S2CID 215794669. - ^ Petrescu AD, Kain J, Liere V, Heavener T, DeMorrow S (2018). "Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease". Frontiers in Endocrinology. 9: 660. doi:10.3389/fendo.2018.00660. PMC 6240761. PMID 30483216.
- ^ a b Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, et al. (April 2013). "Reduced cortisol metabolism during critical illness". The New England Journal of Medicine. 368 (16): 1477–88. doi:10.1056/NEJMoa1214969. PMC 4413428. PMID 23506003.
- ^ Nasiri M, Nikolaou N, Parajes S, Krone NP, Valsamakis G, Mastorakos G, et al. (August 2015). "5
α -Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes". Endocrinology. 156 (8): 2863–71. doi:10.1210/en.2015-1149. PMC 4511138. PMID 25974403. - ^ Hazlehurst JM, Oprescu AI, Nikolaou N, Di Guida R, Grinbergs AE, Davies NP, et al. (January 2016). "Dual-5
α -Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man". The Journal of Clinical Endocrinology and Metabolism. 101 (1): 103–13. doi:10.1210/jc.2015-2928. PMC 4701851. PMID 26574953.
Further reading[edit]
- Levy HR, Talalay P (August 1959). "Bacterial oxidation of steroids. II. Studies on the enzymatic mechanism of ring A dehydrogenation". The Journal of Biological Chemistry. 234 (8): 2014–21. doi:10.1016/S0021-9258(18)69859-X. PMID 13673006.
External links[edit]
- Testosterone+5-alpha-Reductase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)